姓名：伍宇思

照片：

职称：讲师

研究生招生专业：药理学，护理学

电子邮箱：yusiwu@hunnu.edu.cn

通讯地址：湖南长沙岳麓区桐梓坡路371号，3522集团的新网站，410013

简介：

伍宇思，中南大学与加州大学洛杉矶分校联合培养博士，硕士生导师。湖南省健康管理学会肺血管病健康管理专业委员会委员。主要从事心血管药理学与血管疾病的机制与转化研究、慢病健康管理，在Hypertension、Redox Biology、European journal of Pharmacology等杂志发表SCI论文多篇，受邀担任Hypertension等杂志审稿人。

代表性学术论文：

(1)Yusi Wu^#, Bingjie Pan^#, Zhen Zhang, Xiaohui Li, Yiping Leng, Yong Ji, Kun Sun^*, Alex F Chen^*. Caspase-4/11-Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension.Hypertension. 2022 Mar;79(3):536-548.

(2) Kai Huang^#,Yusi Wu^#, Yixuan Zhang, Ji Youn Youn, Hua Cai^*. Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication.Redox Biology. 2022 Dec;58:102521.

(3) Meiling Wang^#,Yusi Wu^#, Yanrong Yu, Yanqi Fu, Hang Yan, Xiaoying Wang, Tingting Li, Weijie Peng^*, Dan Luo^*. Rutaecarpine prevented ox-LDL-induced VSMCs dysfunction through inhibiting overexpression of connexin 43.European Journal Of Pharmacology. 2019 Jun 15;853:84-92.

(4) Ji Youn Youn^#, Yixuan Zhang^#,Yusi Wu, Maxime Cannesson, Hua Cai^*. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.Redox Biology. 2021 Oct;46:102099.

(5) Kai Huang^#, Taro Narumi^#, Yixuan Zhang, Qiang Li, Priya Murugesan,Yusi Wu,Norika Mengchia Liu, Hua Cai^*. Targeting MicroRNA-192-5p, a Downstream Effector of NOXs (NADPH Oxidases), Reverses Endothelial DHFR (Dihydrofolate Reductase) Deficiency to Attenuate Abdominal Aortic Aneurysm Formation.Hypertension. 2021 Aug;78(2):282-293.

硕士生培养：

培养硕士研究生3名。